Pharmacological analysis of doxorubicin in genetically engineered human iPS cell-derived cardiomyocytes

被引：0
|
作者：
Hayashi, Erina [1 ]
Fujizuka, Miki [1 ]
Furukawa, Tetsushi [1 ]
Kurokawa, Junko [1 ]
机构：
[1] Tokyo Med Dent Univ, MRI, Dept Bioinform Pharmacol, Tokyo, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2015年 / 128卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P1-83
引用
收藏
页码：S172 / S172
页数：1
相关论文
共 50 条
  • [31] Evaluation of human iPS cell-derived cardiomyocytes in high-throughput toxicity screening applications
    Cho, Gunsik
    Kwon, Hyosung
    Kim, Dongkyu
    Horvath, Andras
    Becker, Nadine
    Juhasz, Krisztina
    Dragicevic, Elena
    Stoelzle-Feix, Sonja
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2020, 105
  • [32] Evaluation of human iPS cell-derived cardiomyocytes in high-throughput toxicity screening applications
    Ameen, Caroline
    Dahlenborg, Kerstin
    Akesson, Karolina
    Flood, Maria
    Aspegren, Anders
    Juhasz, Krisztina
    Stoelzle-Feix, Sonja
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2018, 93 : 161 - 161
  • [33] Proarrhythmia risk assessment by electro-mechanical window in human iPS cell-derived cardiomyocytes
    Yanagida, Shota
    Satsuka, Ayano
    Hayashi, Sayo
    Ono, Atsushi
    Kanda, Yasunari
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2022, 117
  • [34] Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts
    Shiba, Yuji
    Gomibuchi, Toshihito
    Seto, Tatsuichiro
    Wada, Yuko
    Ichimura, Hajime
    Tanaka, Yuki
    Ogasawara, Tatsuki
    Okada, Kenji
    Shiba, Naoko
    Sakamoto, Kengo
    Ido, Daisuke
    Shiina, Takashi
    Ohkura, Masamichi
    Nakai, Junichi
    Uno, Narumi
    Kazuki, Yasuhiro
    Oshimura, Mitsuo
    Minami, Itsunari
    Ikeda, Uichi
    NATURE, 2016, 538 (7625) : 388 - +
  • [35] The first reported generation of human induced pluripotent stem cells (iPS cells) and iPS cell-derived cardiomyocytes in the Netherlands
    Freund, C.
    Davis, R. P.
    Gkatzis, K.
    Ward-van Oostwaard, D.
    Mummery, C. L.
    NETHERLANDS HEART JOURNAL, 2010, 18 (01) : 51 - 54
  • [36] Biological Pacemaker Created by HCN4-Overexpressing Human iPS Cell-Derived Cardiomyocytes
    Nakamura, Kazufumi
    Saito, Yukihiro
    Yoshida, Masashi
    Akazawa, Kaoru
    Nishii, Nobuhiro
    Miyoshi, Toru
    Ito, Hiroshi
    CIRCULATION, 2018, 138
  • [37] Simultaneous Comparison of Optical Action Potential and Field Potential in Human iPS Cell-Derived Cardiomyocytes
    Taniguchi, Tomohiko
    Sawada, Kohei
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2017, 88 : 189 - 189
  • [38] Engineered Cardiac Tissues Utilizing Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Wendel, J. S.
    Tranquillo, R. T.
    TISSUE ENGINEERING PART A, 2014, 20 : S31 - S32
  • [39] Future treatment of the heart failure and pathophysiological analysis of various heart diseases using human iPS cell-derived cardiomyocytes
    Fukuda, Keiichi
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2013, 63 : S61 - S61
  • [40] Human iPS Cell-derived Tissue Engineered Vascular Graft: Recent Advances and Future Directions
    Xiangyu Shi
    Lile He
    Shang-Min Zhang
    Jiesi Luo
    Stem Cell Reviews and Reports, 2021, 17 : 862 - 877
12345